Plasma platelet-activating factor acetylhydrolase deficiency is associated with atherosclerotic occlusive disease in Japan

Journal of Vascular Surgery

Volumn 32, Issue 2, 2000, Pages 263-267

  Unno, Naoki ^a   Nakamura, Toshio ^a   Kaneko, Hiroshi ^a   Uchiyama, Takashi ^a   Yamamoto, Naoto ^a   Sugatani, Junko ^b   Miwa, Masao ^b   Nakamura, Satoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE;

AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME DEFICIENCY; FEMALE; GENETIC RISK; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0033844713     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2000.105670     Document Type: Article

References (18)

1. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein
2. Characterization of serum platelet-activating factor (PAF) acetylhydrolase: Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children
3. Platelet-activating factor acetylhydrolase deficiency: A missense mutation near the active site of an anti-inflammatory phospholipase
4. 279-Phe) is a genetic risk factor for stroke
5. Roles of plasma platelet-activating factor acetylhydrolase in allergic, inflammatory, and atherosclerotic diseases
6. 994-T missence mutation in exon 9 of the plasma platelet-activating factor acetylhydrolase gene as an independent risk factor for coronary artery disease in Japanese men
7. What effect does controlling platelets have on atherosclerosis?
8. Atherosclerosis: An inflammatory disease
9. The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low-density lipoprotein
10. 281→Arg mutation
11. Plasma from atherosclerotic patients exerts an increased degradation of platelet-activating factor
12. The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients
13. Plasma platelet-activating factor degradation in patients with severe coronary artery disease
14. Decreased plasma platelet-activating factor acetylhydrolase in patients presenting with acute myocardial infarction
15. Human macrophages secrete platelet-activating factor acetylhydrolase
16. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis: In vitro and in vivo inibition by WEB2086
17. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese
18. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction